My 11 year old has been in the diagnostic process for Cystic Fibrosis. Today she had her second Nasal Potential Difference test as part of this process. We know she has the G542X mutation M470V polymorphism and 8G>C polymorphism as well as 7T and 9T variants. The first NPD test showed significant decrease in CFTR function, but her baseline number was not indigitive of CF. Tonight I was told her baseline was significantly more negative than her previous NPD test. My daughter was hosptialized for a respirtatory infection 2 days after teh 1st test and I was told the swelling in her nose could have made the baseline normal on the first test. I am anxiously waiting for the docotor to intrepret the results.
So far I found the following information on John Hopkins website that leads me to believe she will have her diagnosis soon. <a href="http://www.hopkinscf.org/main/whatiscf/diag_testnasal.html">http://www.hopkinscf.org/main/whatiscf/diag_testnasal.html</a>
Three specific features of the NPD test distinguish patients with CF:
1. A more negative baseline potential difference.2. A larger inhibition of NPD after addition of amiloride.3. Little or no change in NPD after addition of the chloride-free and isoproterenol solutions.
If anyone has experience with NPD testing as part of the CF diagnostic process I would appreciate any feedback.
So far I found the following information on John Hopkins website that leads me to believe she will have her diagnosis soon. <a href="http://www.hopkinscf.org/main/whatiscf/diag_testnasal.html">http://www.hopkinscf.org/main/whatiscf/diag_testnasal.html</a>
Three specific features of the NPD test distinguish patients with CF:
1. A more negative baseline potential difference.2. A larger inhibition of NPD after addition of amiloride.3. Little or no change in NPD after addition of the chloride-free and isoproterenol solutions.
If anyone has experience with NPD testing as part of the CF diagnostic process I would appreciate any feedback.